Skip to main content
Equibles
AVXL logo

AVXL · Anavex Life Sciences Corp. · Webcasts, Transcripts & Audio

Track AVXL — free

Use AVXL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVXL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.82 -0.07 (-3.70%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$219.69M
Shares
92.70M
Volume · Oct 2 1.99M Avg daily vol (3M) 931.52K

Anavex Life Sciences Corp. Webcasts

Earnings calls, investor updates, investor days and conferences for Anavex Life Sciences Corp. (AVXL), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q3
2026-08-25
Anavex Life Sciences Corp. (AVXL) Q3 2026 Earnings Call
Diluted EPS
$0.08
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-02-09
Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call Transcript
Positive tone Blarcamesine for early Alzheimer's disease Scientific publications and presentations FDA Type C meeting feedback
Diluted EPS
$-0.06
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-25
Anavex Life Sciences Corp. (AVXL) Q4 2025 Earnings Call Transcript
Positive tone Long-term Blacaramazine clinical efficacy data ANAVEX 371 schizophrenia Phase 2 results Precision medicine / genetic subpopulations (ABCLEAR)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-06-30
Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call Transcript
Confident tone Blarcamesine / ANAVEX 2-73 in Alzheimer's EMA regulatory review Rett syndrome program
Diluted EPS
$-0.16
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-03-31
Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript
Confident tone Blarcamesine for Alzheimer's disease Schizophrenia program (ANAVEX3-71) EMA regulatory review
Diluted EPS
$-0.13
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-12-31
Anavex Life Sciences Corp. (AVXL) Q1 2025 Earnings Call Transcript
Confident tone Blarcamesine for Early Alzheimer's Disease European Regulatory Review (EMA) Comparison to Monoclonal Antibodies (Kisunla/donanemab)
Diluted EPS
$-0.14
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-09-30
Anavex Life Sciences Corp. (AVXL) Q4 2024 Earnings Call Transcript
Confident tone Blacamasent EMA MAA acceptance for Alzheimer's Attention AD/OLE long-term data and publication Blacamasent clinical efficacy and mechanism of action
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-05-09
Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript
Confident tone Blarcamesine (ANAVEX®2-73) in Alzheimer's Disease ANAVEX®3-71 in Schizophrenia European MAA Submission
Diluted EPS
$-0.13
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-09-30
Anavex Life Sciences Corp. (AVXL) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-06-30
Anavex Life Sciences Corp. (AVXL) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.14
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-03-31
Anavex Life Sciences Corp. (AVXL) Q2 2023 Earnings Call Transcript
Diluted EPS
$-0.17
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-12-31
Anavex Life Sciences Corp. (AVXL) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.17
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-09-30
Anavex Life Sciences Corp. (AVXL) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-06-30
Anavex Life Sciences Corp. (AVXL) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-03-31
Anavex Life Sciences Corp. (AVXL) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-12-31
Anavex Life Sciences Corp. (AVXL) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-09-30
Anavex Life Sciences Corp. (AVXL) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-06-30
Anavex Life Sciences Corp. (AVXL) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-03-31
Anavex Life Sciences Corp. (AVXL) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-12-31
Anavex Life Sciences Corp. (AVXL) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-28
Anavex Life Sciences Corp. (AVXL) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-06-30
Anavex Life Sciences Corp. (AVXL) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 webcasts
Key facts CIK 1314052 CUSIP 032797300 13F (30d) 5 filings 5 filers Visit website Investor relations